These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11201893)

  • 41. Leprosy chemoprophylaxis in Micronesia.
    Diletto C; Blanc L; Levy L
    Lepr Rev; 2000 Dec; 71 Suppl():S21-3; discussion S24-5. PubMed ID: 11201881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India.
    Lavania M; Darlong J; Singh I; Ahuja M; Turankar RP; Pathak VK; Kumar A; Nathan R; Sengupta U
    J Glob Antimicrob Resist; 2020 Dec; 23():275-277. PubMed ID: 33068781
    [No Abstract]   [Full Text] [Related]  

  • 43. In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues.
    Dhople AM; Namba K
    Int J Antimicrob Agents; 2003 Mar; 21(3):251-5. PubMed ID: 12636987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histoid leprosy: case report.
    Bakry OA; Attia AM
    Acta Dermatovenerol Croat; 2012; 20(4):256-9. PubMed ID: 23317487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Newer drugs in leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic prospects for paucibacillary leprosy.
    Katoch K
    Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
    [No Abstract]   [Full Text] [Related]  

  • 47. Chemotherapy of leprosy.
    Biswas SK;
    J Indian Med Assoc; 2004 Dec; 102(12):695-6, 698. PubMed ID: 15871354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of leprosy.
    Kar HK; Gupta R
    Clin Dermatol; 2015; 33(1):55-65. PubMed ID: 25432811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serological response to chemoprophylaxis in extended contacts in leprosy--a randomized controlled trial.
    Oo KN; Yin NN; Han TT; Wai KT; Myint K; Gyi MM
    Nihon Hansenbyo Gakkai Zasshi; 2008 Feb; 77(1):3-10. PubMed ID: 18341017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leucocytopenia after rifampicin and ofloxacin therapy in leprosy.
    Vijayakumaran P; Manimozhi N; Jesudasan K; Arunthathi S; Jacob M; Samuel P
    Lepr Rev; 1997 Mar; 68(1):10-5. PubMed ID: 9121326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Granuloma annulare treated with rifampin, ofloxacin, and minocycline combination therapy.
    Marcus DV; Mahmoud BH; Hamzavi IH
    Arch Dermatol; 2009 Jul; 145(7):787-9. PubMed ID: 19620560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomised controlled trial assessing the effect of adding clarithromycin to rifampicin, ofloxacin and minocycline in the treatment of single lesion paucibacillary leprosy in Agra District, India.
    Girdhar A; Kumar A; Girdhar BK
    Lepr Rev; 2011 Mar; 82(1):46-54. PubMed ID: 21644471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical, bacteriological and histopathological study of 62 referral relapse cases between Jan 2004 and Dec 2009 at the Foundation for Medical Research, Mumbai.
    Shetty VP; Wakade AV; Ghate SD; Pai VV
    Lepr Rev; 2011 Sep; 82(3):235-43. PubMed ID: 22125931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse effects of alternative therapy (minocycline, ofloxacin, and clofazimine) in multibacillary leprosy patients in a recognized health care unit in Manaus, Amazonas, Brazil.
    Maia MV; Cunha Mda G; Cunha CS
    An Bras Dermatol; 2013; 88(2):205-10. PubMed ID: 23739719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidrug therapy: reply to letters.
    Ji B
    Lepr Rev; 1999 Sep; 70(3):367-8. PubMed ID: 10603729
    [No Abstract]   [Full Text] [Related]  

  • 56. Multidrug therapeutic challenges in leprosy.
    Jain S; Sehgal VN
    Int J Dermatol; 1997 Jul; 36(7):493-6. PubMed ID: 9268743
    [No Abstract]   [Full Text] [Related]  

  • 57. Population screening and chemoprophylaxis for household contacts of leprosy patients in the Republic of the Marshall Islands.
    Tin K
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S26-9. PubMed ID: 10700934
    [No Abstract]   [Full Text] [Related]  

  • 58. [Guideline for the treatment of leprosy by new quinolones].
    Gidoh M; Namisato M; Kumano K; Goto M; Nogami R; Ozaki M;
    Nihon Hansenbyo Gakkai Zasshi; 2004 Feb; 73(1):65-7. PubMed ID: 15035068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
    Sousa AL; Stefani MM; Pereira GA; Costa MB; Rebello PF; Gomes MK; Narahashi K; Gillis TP; Krahenbuhl JL; Martelli CM
    Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
    Singh HB; Katoch K; Natrajan M; Sharma RK; Gupta UD; Sharma VD; Singh D; Chauhan DS; Srivastava K; Katoch VM
    Acta Leprol; 1999; 11(4):179-82. PubMed ID: 10987049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.